Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia in Fetuses With Intrauterine Renal Failure or Severe Renal Anomalies- a Feasibility Study

NCT03723564 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03723564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03723564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia in Fetuses With Intrauterine Renal Failure or Severe Renal Anomalies- a Feasibility Study
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Recruiting
Start date
October 1, 2018
Completion date
December 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital renal anomaly nos, lower urinary tract obstructive syndrome, renal agenesis and dysgenesis, renal failure congenital